|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2250 AUD | 0.00% |
|
+2.27% | -32.84% |
| 06-09 | Compumedics Limited Announces Appointment of Mike Stone as Chief Commercial Officer for Its US Operations | CI |
| 04-20 | Compumedics Sees Fiscal Year 2026 EBITDA of Up to AU$7 Million | MT |
Company Valuation: Compumedics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 69.98 | 59.35 | 48.97 | 44.95 | - | - |
| Change | - | - | -17.49% | -8.22% | - | - |
| Enterprise Value (EV) | 69.98 | 59.35 | 48.97 | 44.95 | 44.95 | 44.95 |
| Change | - | - | -17.49% | -8.22% | 0% | 0% |
| P/E | 65.8x | -335x | -36.4x | 15x | 6.08x | 4.41x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | -0x | -0x | 0x | 0.1x |
| Capitalization / Revenue | 1.96x | - | 0.96x | 0.68x | 0.56x | 0.47x |
| EV / Revenue | 0x | - | 0x | 0.68x | 0.56x | 0.47x |
| EV / EBITDA | 0x | - | 0x | 6.24x | 3.38x | 2.58x |
| EV / EBIT | 0x | - | 0x | 9.36x | 4.12x | 3.04x |
| EV / FCF | -0x | - | -0x | 30x | 8.64x | 5.91x |
| FCF Yield | -0.33% | - | -13.7% | 3.34% | 11.6% | 16.9% |
| Dividend per Share 2 | - | - | - | - | 0.02 | 0.028 |
| Rate of return | - | - | - | - | 8.89% | 12.4% |
| EPS 2 | 0.006 | -0.001 | -0.007 | 0.015 | 0.037 | 0.051 |
| Distribution rate | - | - | - | - | 54.1% | 54.9% |
| Net sales 1 | 35.74 | - | 50.96 | 66.3 | 79.7 | 95.2 |
| EBITDA 1 | 2.563 | - | 2.938 | 7.2 | 13.3 | 17.4 |
| EBIT 1 | 1.106 | - | 0.692 | 4.8 | 10.9 | 14.8 |
| Net income 1 | 0.998 | -0.499 | -1.272 | 3.8 | 9 | 12.8 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 0.3950 | 0.3350 | 0.2550 | 0.2250 | 0.2250 | 0.2250 |
| Nbr of stocks (in thousands) | 177,163 | 177,163 | 192,039 | 199,762 | - | - |
| Announcement Date | 8/26/21 | 8/30/24 | 8/26/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15x | - | - | -.--% | 31.47M | ||
| 26.8x | 4.81x | 18.5x | 0.35% | 202B | ||
| 32.49x | 6.29x | 19.78x | 0.71% | 145B | ||
| 43.01x | 11.17x | 24.97x | -.--% | 142B | ||
| 15.83x | 3.27x | 10.52x | -.--% | 66.32B | ||
| 31.12x | 6.97x | 22.22x | -.--% | 50.58B | ||
| 18.43x | 2.12x | 10.99x | 2.85% | 44.81B | ||
| 26.2x | 5.22x | 17.82x | 0.76% | 38.44B | ||
| 45.44x | 6.34x | 19.49x | -.--% | 37.13B | ||
| 14.2x | 1.58x | 8.82x | 0.25% | 29.89B | ||
| Average | 26.85x | 5.31x | 17.01x | 0.49% | 75.67B | |
| Weighted average by Cap. | 30.16x | 6.11x | 18.70x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CMP Stock
- Valuation Compumedics Limited
Select your edition
All financial news and data tailored to specific country editions
















